Patient-reported outcome measures improve survival risk and quality of life for cancer patients, according to a study published Aug. 13 in JAMA Network Open. PROMs are self-reported statements from ...

Providing the best patient-centered care, as measured by the individual patient's perceived value of care at a reasonable cost, has become the established definition of value-based health care (VBHC).

Patient-reported outcome measures utilising a symptom questionnaire do not appear to expedite how quickly diagnosed depression symptoms dissipate nor do they improve overall social functioning or ...

ACR-368, a CHK1/2 Kinase Inhibitor, in Patients With Relapsed or Refractory Desmoplastic Small Round Cell Tumor: Phase I/II Trial Results Patients diagnosed with hereditary RC are more prone to ...

A new policy review published in The Lancet Oncology and led by Ian Tannock and Madeline Pe, together with an international team of oncologists, statisticians, patients and patient-reported outcomes ...

Please provide your email address to receive an email when new articles are posted on . CMS established a policy to standardize PROMs collection and reporting. There are several barriers to PROMs data ...

Incorporating patient-reported outcome measures, such as quality of life, as well as looking into real-world data, is important when assessing how to treat a patient with psoriasis, says James Song, ...

Patient-reported outcome measures (PROMs) are crucial tools for assessing the health and well-being of children, yet their application in pediatrics faces unique challenges due to developmental ...

This is a preview. Log in through your library . Abstract Purpose Patient-reported outcome measures (PROMs) are standardized instruments used to collect data about the subjective assessment of medical ...

The evaluation of cataract surgery outcomes has evolved beyond simple measures of visual acuity. Contemporary research incorporates patient‐reported measures that capture self‐assessed visual function ...

An expert discusses how rilzabrutinib uniquely improves quality-of-life metrics, including fatigue and women’s health domains, which previous immune thrombocytopenia (ITP) therapies failed to address ...

Please provide your email address to receive an email when new articles are posted on . FRANKFURT, Germany — In this Healio Video Perspective from the ESCRS winter meeting, Anders Behndig, MD, PhD, ...